Literature DB >> 8303720

Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom.

R Giorgi1, M M Bernardi, Y Cury.   

Abstract

Crude venom obtained from Crotalus durissus terrificus (Cdt) was tested for its possible analgesic effect in mice. Subcutaneous (s.c.), intraperitoneal (i.p.) or oral (p.o.) administration of the venom caused an antinociceptive effect in mice as measured by the acetic acid-induced writhing method and the hot plate test. The antinociceptive activity was dose and time dependent and persisted after neutralization of the venom with a specific antivenin. It was demonstrated that the factor(s) has an apparent mol. wt of less than 3000 and that its antinociceptive effect is abolished by trypsin treatment. The demonstration that morphine enhances the analgesic effect of Cdt venom and naloxone antagonizes this effect suggests an endorphin-like activity for the factor(s) herein described.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8303720     DOI: 10.1016/0041-0101(93)90399-4

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  13 in total

1.  Structure of the polypeptide crotamine from the Brazilian rattlesnake Crotalus durissus terrificus.

Authors:  Monika A Coronado; Azat Gabdulkhakov; Dessislava Georgieva; Banumathi Sankaran; Mario T Murakami; Raghuvir K Arni; Christian Betzel
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20

2.  Verrucotoxin, a stonefish venom, modulates calcium channel activity in guinea-pig ventricular myocytes.

Authors:  K Yazawa; J-W Wang; L-Y Hao; Y Onoue; M Kameyama
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

3.  Acute toxicity, antinociceptive, and anti-inflammatory activities of the orally administered crotamine in mice.

Authors:  Lorena A Moreira; Lanussy P Oliveira; Marta R Magalhães; Sayonara A M Oliveira; Jerônimo R Oliveira-Neto; Pablinny M G Carvalho; Adryano A V Carvalho; James O Fajemiroye; Alessandro C Cruz; Luiz C Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-20       Impact factor: 3.000

4.  The first report on the medicinal use of fossils in latin america.

Authors:  Geraldo Jorge Barbosa Moura; Ulysses Paulino Albuquerque
Journal:  Evid Based Complement Alternat Med       Date:  2011-09-29       Impact factor: 2.629

5.  Differential Effects of Naja naja atra Venom on Immune Activity.

Authors:  Jian-Qun Kou; Rong Han; Yin-Li Xu; Xiao-Lan Ding; Shu-Zhi Wang; Cao-Xin Chen; Hong-Zhang Ji; Zhi-Hui Ding; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-12       Impact factor: 2.629

6.  Antinociceptive and anti-inflammatory effects of orally administrated denatured naja naja atra venom on murine rheumatoid arthritis models.

Authors:  Kou-Zhu Zhu; Yan-Li Liu; Jin-Hua Gu; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

7.  The venom of South American rattlesnakes inhibits macrophage functions and is endowed with anti-inflammatory properties.

Authors:  M C Silva; L R Gonçalves; M Mariano
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

8.  The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy.

Authors:  Shu-Zhi Wang; He He; Rong Han; Jia-Li Zhu; Jian-Qun Kou; Xiao-Lan Ding; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

9.  Suppression of Inflammation and Arthritis by Orally Administrated Cardiotoxin from Naja naja atra.

Authors:  Cao-Xin Chen; Jie-Yu Chen; Jian-Qun Kou; Yin-Li Xu; Shu-Zhi Wang; Qi Zhu; Lu Yang; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-12       Impact factor: 2.629

10.  Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.

Authors:  Carolina Alves Nicolau; Alyson Prorock; Yongde Bao; Ana Gisele da Costa Neves-Ferreira; Richard Hemmi Valente; Jay William Fox
Journal:  Toxins (Basel)       Date:  2018-02-06       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.